Vivos Therapeutics vs Jin Medical International
Jin Medical International is the larger business, with $20.7m of revenue in fiscal 2025 against $17.4m for Vivos Therapeutics (1.2 times as much). Vivos Therapeutics grew faster (16.0% against -12.0%). Jin Medical International kept more of each dollar of sales as profit: a net margin of 5.8% against -121.4%.
| Latest fiscal year | Vivos TherapeuticsVVOS, 2025 | Jin Medical InternationalZJYL, 2025 |
|---|---|---|
| Revenue | $17.4m | $20.7m |
| Revenue growth | 16.0% | -12.0% |
| Net income | −$21.2m | $1.2m |
| Operating margin | -114.1% | — |
| Net margin | -121.4% | 5.8% |
| Return on equity | — | 4.1% |
| Free cash flow | −$17.6m | −$3.7m |
| Cash | $2.0m | $7.5m |
| Total debt | $19.3m | $18.8m |
| Debt to equity | — | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 268 | — |
| Market value | $1.6m | $412m |
| Price vs our value range | — | — |
| Moat score | 30 (Weak) | — |
| Insider trades, 12 months | 2 buys, 0 sales | 0 buys, 0 sales |